VenoStent Patents

Patent portfolio assigned to VenoStent (verified via public assignee records). Clinical-stage medical device co (SelfWrap bioabsorbable perivascular wrap; FDA Breakthrough Device). Pre-commercial, so no customers. Patent applications exist with assignee 'Venostent, Inc.' per inventor/patent search (count not precisely confirmed). Competitors are other vascular-access device firms (Avenu Medical via ZoomInfo); Humacyte is an adjacent bioengineered vascular peer — competitor list is approximate given early stage.